Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

ML 1035

Known as: ML-1035 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A fully automated column-switching HPLC procedure has been developed and validated for quantitation of ML-1035 and its five… Expand
1994
1994
Abstract— 4‐Amino‐5‐chloro‐substituted benzamides have been shown to increase gastric motility in‐vivo and enhance field… Expand
1994
1994
Methods are discussed which permit the calculation of the bioavailability (F) and fraction of an oral dose entering the central… Expand
1993
1993
ML-1035, 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethyl-amino)ethyl]benzamide, is a sulfoxide compound and a… Expand
1993
1993
The pharmacokinetics of a new 5-hydroxytryptamine (5HT3) receptor antagonist, 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2… Expand
1992
1992
The disposition of 4‐amino‐5‐chloro‐2‐[2‐(methylsulfinyl)ethoxy]‐N‐[2‐(diethylamino) ethyl] benzamide hydrochloride (ML‐1035… Expand
1991
1991
Serotonin (5-HT) receptors in the myenteric plexus mediate contractility in vitro and may regulate gastric emptying in vivo. This… Expand
1991
1991
A fully automated column-switching LC assay has been developed for the simultaneous determination of a gastroprokinetic agent, ML… Expand
1991
1991
ML-1035, is a gastroprokinetic agent structurally related to metoclopramide. Because ML-1035 contains an asymmetric chiral… Expand